Home / Biosimilars

Biosimilars

News

Insulin glargine biosimilar Semglee launched in US posted 18/09/2020

The partnership of US-based drugmaker Mylan and Indian biologicals specialist Biocon announced on 31 August 2020 the lau...

Cadila Pharmaceuticals launches two similar biologics in India posted 15/09/2020

Indian generics maker Cadila Pharmaceuticals Ltd (Cadila) has launched two new similar biologics in the country: Bevaro (beva...

Turkey 2016 COVER V16E31DG Samsung Bioepis launches Ontruzant in Brazil posted 15/09/2020

South Korean biotechnology company Samsung Bioepis has announced the launch of their trastuzumab biosimilar Ontruzant in Braz...

EC approval for trastuzumab biosimilar Zercepac posted 08/09/2020

The European Commission (EC) has granted marketing authorization for the trastuzumab biosimilar Zercepac (HLX02) on 27 July 2...

EMA recommends approval of bevacizumab biosimilar Equidacent posted 07/09/2020

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 23 July 2020 that it...

 

Research

What oncologists do not understand about biosimilars posted 23/09/2020

The availability of biosimilars may improve access to health care by increasing the number of therapeutic options available a...

Biosimilars allow fast access to biological drug therapy in Bavaria, Germany posted 18/09/2020

A new study has shown that patients suffering from rheumatism in Bavaria, Germany, are now likely to be prescribed a biologic...

Celltrion’s biosimilars effective against gastric cancer and B-cell lymphoma posted 15/09/2020

Recent clinical trial results confirm that Celltrion’s biosimilars Herzuma (trastuzumab) and Truxima (rituximab) are effectiv...

Budget savings from biosimilar infliximab in the UK, France, Japan and Korea posted 11/09/2020

Biological medicines are attracting attention from policymakers and health insurers across countries due to their increased f...

ST002293 Monoclonal antibody biosimilars and cancer in the EU posted 08/09/2020

Spanish researchers investigated the current status of biosimilar monoclonal antibodies (mAbs) in the European Union (EU) by...

 

General

Country scorecards show biosimilar sustainability posted 18/09/2020

Biosimilars are an important component of sustainable health systems as they provide alternatives to originator biological pr...

Duopharma to establish Malaysia’s first commercial biosimilar facility posted 11/09/2020

Malaysia-based manufacturer Duopharma Biotech aims to establish Malaysia’s first commercial biosimilar production facility. T...

WHO prequalifies Celltrion’s trastuzumab biosimilar Herzuma posted 08/09/2020

The World Health Organization (WHO) has prequalified Celltrion Healthcare’s second biosimilar, a trastuzumab biosimilar sold...

Clinical trials for trastuzumab biosimilars posted 31/08/2020

Roche’s originator trastuzumab biological (Herceptin) was approved by the US Food and Drug Administration (FDA) in September...

ST002293 Biosimilar pipelines for Korean firms looking healthy posted 24/07/2020

Korean companies are becoming more and important both in the country but also worldwide when it comes to developing biosimilars.